ArticleClinical epigenetics2021

Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.

Yin-Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.